Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;176(12):1260-1261.
doi: 10.1001/jamapediatrics.2022.3251.

Antenatal Steroid Exposure Among Term Newborns

Affiliations

Antenatal Steroid Exposure Among Term Newborns

Taylor S Freret et al. JAMA Pediatr. .
No abstract available

Plain language summary

This cross-sectional study evaluates the association between dissemination of the Antenatal Late Preterm Steroid trial and changes in steroid exposure among term newborns.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Melamed reported receiving grants from the National Center for Advancing Translational Sciences, the National Cancer Institute, and the Conquer Cancer–The ASCO Foundation outside the submitted work. Dr Gyamfi-Bannerman reported receiving grants from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities and receiving personal fees from Medela and Hologic for lectures outside the submitted work. Dr Clapp reported receiving grants from the American Association of Obstetricians and Gynecologists Foundation and the Risk Management Foundation of the Harvard Medical Institutions, Inc., and serving as a Medical Advisory Board member with and holding private equity in Delflina Health outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flowchart of Inclusion and Exclusion Criteria
ALPS trial indicates Antenatal Late Preterm Steroid trial.
Figure 2.
Figure 2.. Expected and Observed Antenatal Steroid Exposure Rates Among Term Newborns
Models were controlled for gestational age at delivery, maternal age, race, Hispanic ethnicity, primary payer for delivery admission, and delivery practitioner type. Race and Hispanic ethnicity were collected by self-report from birth certificate data and were reported to account for potential variation in steroid administration rates in different groups. Markers indicate estimates for monthly steroid administration; vertical lines, 95% CIs; shading, Antenatal Late Preterm Steroid trial dissemination period; solid lines, observed trends; and dashed line, expected trend.

Comment in

References

    1. Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. ; NICHD Maternal–Fetal Medicine Units Network . Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311-1320. doi:10.1056/NEJMoa1516783 - DOI - PMC - PubMed
    1. Clapp MA, Melamed A, Freret TS, James KE, Gyamfi-Bannerman C, Kaimal AJ. US incidence of late-preterm steroid use and associated neonatal respiratory morbidity after publication of the Antenatal Late Preterm Steroid trial, 2015-2017. JAMA Netw Open. 2022;5(5):e2212702. doi:10.1001/jamanetworkopen.2022.12702 - DOI - PMC - PubMed
    1. Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS; Society for Maternal-Fetal Medicine (SMFM) . Society for Maternal-Fetal Medicine consult series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. Am J Obstet Gynecol. 2021;225(5):B36-B42. doi:10.1016/j.ajog.2021.07.023 - DOI - PubMed
    1. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice; Society for Maternal-Fetal Medicine . Committee opinion No. 677: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2016;128(4):e187-e194. doi:10.1097/AOG.0000000000001715 - DOI - PubMed
    1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515-525. doi:10.1542/peds.50.4.515 - DOI - PubMed